Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel® implantation - Incidence, therapeutic strategies, and outcome

Journal of Clinical Neuroscience

Volumn 18, Issue 3, 2011, Pages 347-351

  Dörner, Lutz ^a   Ulmer, Stephan ^a   Rohr, Axel ^a   Mehdorn, H Maximilian ^a   Nabavi, Arya ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

BCNU wafer; Cyst; Gliadel ; Malignant glioma; Mass effect

Indexed keywords

CARMUSTINE; DEXAMETHASONE;

ADULT; AGED; ARTICLE; BRAIN CYST; CANCER SURGERY; CHEMOTHERAPY; DECOMPRESSION; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; IMPLANTATION; INCIDENCE; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOCOMPATIBLE MATERIALS; BRAIN NEOPLASMS; CARMUSTINE; CENTRAL NERVOUS SYSTEM CYSTS; DECANOIC ACIDS; DRAINAGE; FEMALE; GLIOMA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; POLYESTERS; TREATMENT OUTCOME;

EID: 79551571702     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.05.036     Document Type: Article

References (10)

1. H. Brem, S. Piantadosi, and P.C. Burger Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas Lancet 345 1995 1008 1012
2. M. Westphal, D.C. Hilt, and E. Bortey A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafer (Gliadel wafers) in patients with primary malignant glioma Neuro Oncol 5 2003 79 88
3. H.C. Lawson, P. Sampath, and E. Bohan Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience J Neurooncol 83 2006 61 67
4. M. Sabel, and A. Giese Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience Curr Med Res Opin 24 2008 3239 3257
5. J.P. Dyke, P.C. Sanelli, and H.U. Voss Monitoring the effects of the BCNU chemotherapy wafers (Gliadel®) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla J Neurooncol 82 2006 103 110
6. S. Kunwar, M.D. Prados, and S.M. Chang Direct intracerebral delivery of cintredekin besudotox (Il13-PE38QQR) in recurrent malignant glioma: a report by the cintredekin besudotox intraparenchymal study group J Clin Oncol 25 2007 837 844
7. H.H. Engelhard Tumor bed cyst formation after BCNU wafer implantation: report of two cases Surg Neurol 53 2000 220 224
8. M.J. McGirt, A.T. Villavicencio, and K.R. Bulsara Management of tumor bed cysts after chemotherapeutic wafer implantation J Neurosurg 96 2002 941 945
9. A. Giese, T. Kucinski, and U. Knopp Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma J Neurooncol 66 2004 351 360
10. L.R. Kleinberg, J. Weingart, and P. Burger Clinical course and pathological findings after Gliadel® and radiotherapy for newly diagnosed malignant glioma: implications for patients' management Cancer Invest 22 2004 1 9